How Pharmaceutical Companies Can Take Advantage of the EHR Revolution

Electronic Health Reporter

The article How Pharmaceutical Companies Can Take Advantage of the EHR Revolution appeared first on electronichealthreporter.com. Editorial electronic health records formularies are standardized PharmaceuticalThis content is copyrighted strictly for Electronic Health Reporter.

Harnessing Innovation to Serve and Create Value for Patients

Electronic Health Reporter

By Georgia Mitsi, PhD, MBA, senior director and head of digital healthcare initiatives, Sunovion Pharmaceuticals Inc. Editorial Georgia Mitsi improving patient care Sunovion PharmaceuticalsThis content is copyrighted strictly for Electronic Health Reporter.

AHIP18: How Intermountain plans to fight pharmaceutical monopolies as a generic drugmaker

FierceHealthIT

After watching Martin Shkreli raise the price of a drug by more than 550% in 2015, Intermountain's Dan Liljenquist had the same thought as the rest of America: Is this really happening? So the system decided to create a nonprofit generic drug company that Liljenquist calls a “first-of-its-kind societal asset

Employers Take on Health Activism, Embracing Behavioral Health, Virtual Care, AI, and Transparency

Health Populi

One of the most concerning rising cost components in medical trend come from the pharmaceutical supply chain. The vast majority of employers do not believe the current rebate-based system works to reduce pharmaceutical costs, and most welcoming an alternative to rebates. More U.S.

Consumers Changing the Channel on Where They Shop for Health

Health Populi

Consumers who have long purchased over-the-counter medicines, anti-dandruff shampoo, whitening toothpaste, and cosmetics-with-benefits at food, drug and mass merchant retailers are switching to other places to shop for health, new data from AT Kearney and GMDC have found.

CVS + Aetna: Inflection Point in US Healthcare, Merger Approved Update

Health Populi

During the hearing, Senator Patty Murray (D-WA) challenged Azar, “As a pharmaceutical executive, you raised drug prices year after year. CVS Health’s acquisition of Aetna was approved this week by U.S.

Health Care for a Typical Working Family of Four in America Will Cost $28,166 in 2018

Health Populi

What could $28,166 buy you in 2018? A new car? A year of your child’s college education? A plot of land for your retirement home? Or a year of healthcare for a family of four?

Self-Care is Healthcare for Everyday People

Health Populi

Patients are the new healthcare payors, and as such, taking on the role of health consumers. In fact, health and wellness consumers have existed since a person purchased the first toothpaste, aspirin, heating pad, and moisturizing cream at retail.

Healthcare’s Profits Will Be Dramatically Redistributed as Care Shifts to Consumers: Accenture

Health Populi

All sectors who are stakeholders in the healthcare ecosystem aren’t created equal, Accenture explains in their report, Healthcare’s future winners and losers.

Koen Kas, the Gardener of Health Tech Delights

Health Populi

The future of healthcare is not about being sick, Prof. Dr. Koen Kas believes.

How to Make Healthcare More Intelligent and Trustworthy: Accenture’s Digital Health Tech Vision 2018

Health Populi

“Do no harm” has been the professional and ethical mantra of physicians since the Hippocratic Oath was first uttered by medical students. The origins of that three-word objective probably came out of Hippocrates’ Corpus , which included a few additional words: “to do good or to do no harm.”.

Prescription Drugs: From Costs and Bad Reputation to Civica Rx and Amazon to the Rescue

Health Populi

consumers have long-ranked the pharmaceutical industry relatively low, but above car salespeople and the Federal government. The prices of medicines prescribed in outpatient settings rose, on average. 10.3% in 2018.

Doing Less Can Be Doing More for Healthcare – the Biggest Takeaway From ASCO 2018

Health Populi

Less can lead to more for so many things: eating smaller portions, lowering sugar consumption, and driving less in favor of walking or cycling come to mind. When it comes to healthcare utilization, doing less can also result in equal or even better outcomes.

Healthcare Policies We Can Agree On: Pre-Existing Conditions, Drug Prices, and PillPack – the June 2018 KFF Health Tracking Poll

Health Populi

EpiPen pricing mainstreamed the issue of pharmaceutical costs as a democratized (small “d”) issue in 2016, when Mylan grew the cost of a two-pack to about $600. There are countless chasms in the U.S. this moment in social, political, and economic perspectives.

Technology, Aging and Obesity Drive Healthcare Spending, BEA Finds

Health Populi

Financial health Health Consumers Health costs Health Economics Health policy Heart health Medicare Medicines Mental health Money and health Obesity Personal health finance Pharmaceutical Prescription drugs Prevention Public health Specialty drugs TransparencyThe U.S.

How We Spend Versus What We Get: America’s Healthcare Spending Makes for Poor Health

Health Populi

had the highest pharmaceutical spending per capita of $1,443 versus $749 for the other nations, roughly double. The U.S. spent nearly twice as much as other wealthy countries on healthcare, mostly due to higher prices for both labor and products (especially prescription drugs).

The US Covered Nearly 50% of Global Oncology Medicine Spending in 2017 – a market update from IQVIA

Health Populi

Cancer Financial health Financial wellness Global Health Health costs Health finance Health policy Medical innovation Medicines Money and health Pharmaceutical Pharmacy Prescription drugs Specialty drugs Sustainability

Rx 2018: A New Era of Specialty Drugs, Telehealth, Mobile Apps and Value, IQVIA Reports

Health Populi

The report pointed especially to hospital and pharmaceutical prices. President Trump made clear on the campaign trail and in his interview with TIME magazine as Person of the Year that pharmaceutical companies’ pricing needed to be reined in using government pressure.

Healthcare Is Local: Channeling Tip O’Neill in the 2018 Midterm Election Results

Health Populi

Democrats have been committed to the concept of the government negotiating drug prices directly with pharmaceutical companies the way other developed countries do. As Tip O’Neill’s mantra goes, “All politics is local.” ” In the U.S.

What the Pew Data on Americans’ Views on Technology Means for Healthcare

Health Populi

Most Americans say that pharmaceutical manufacturers, banks, advertisers, energy firms, and tech companies have too much power and influence in today’s American economy, according to Public Attitudes Toward Technology Companies , a research report from the Pew Research Center.

Consumers Consider Cost When They Think About Medical Innovation

Health Populi

ACA Affordable Care Act Bio/life sciences Biotech Financial health Financial wellness Health Consumers Health costs Health disparities Health Economics Health finance Health law Health policy Health politics Health reform Medical innovation Medicines Money and health Pharmaceutical Trust

As Medical Cost Trend Remains Flat, Patients Face Growing Health Consumer Financial Stress

Health Populi

When it comes to healthcare costs, lines that decline over time are generally seen as good news. That’s how media outlets will cover the top-line of PwC’s report Medical cost trend: Behind the numbers 2019. However, there are other forces underneath the stable-looking 6.0%

Americans’ Trust in the Healthcare System Low Compared to Rest-of-World’s Health Citizens

Health Populi

In the U.S., trust in the healthcare industry declined by 9 percentage points in just one year, declining from 62% of people trusting — that’s roughly two-thirds of Americans — down to 53% — closer to one-half of the population.

The Gap Between the Trump Administration’s Promise of Reducing Rx Costs for Consumers and What People Really Want

Health Populi

Smart Pharmaceuticals Index (NQSSPH) from May 11, 2018, the date when POTUS and Secretary Azar made their announcement.

The U.S. is a Nation in Pain – America’s Life Expectancy Fell Again in 2016

Health Populi

American saw the greatest number of deaths from suicide and alcohol- and drug-induced fatalities was recorded in 2016. That statistic of nearly 142,000 equates to deaths from stroke and exceed the number of deaths among Americans who died in all U.S.

Pharma Spending Gone Bipolar: Generics At One End, Specialty Drugs on the Other

Health Populi

” These ratings cover over 2,100 pharmaceutical brands for which over 40,000 having submitted opinions. While the use of medicines continues to rise in the U.S., spending grew by only 0.6% in 2017 after accounting for discounts and rebates.

Surprise, Surprise: Most Americans Have Faced a “Surprise” Medical Bill

Health Populi

Most Americans have been surprised by a medical bill, a NORC AmeriSpeak survey found. Who’s responsible? Nearly all Americans (86% net responsible) first blame health insurance companies, followed by hospitals (82%). Fewer U.S.

At BIO 2018, digital technologies in pharma are gaining steam

Mobi Health News

Digital technologies are cementing their place across healthcare, and the pharmaceutical sector is no exception

Pharmacies Continue to Earn Consumer-Love

Health Populi

Among industries that consumers frequent, one continues to delight people more than most: pharmacies. Power’s 2018 ratings on U.S. pharmacies finds that consumers do indeed still love their pharmacies after ten years of rating customer satisfaction with brick-and-mortar and mail order channels.

150 top places to work in healthcare

Henry Kotula

[link]. Becker’s Healthcare is pleased to release the “150 Top Places to Work in Healthcare | 2018” list, which highlights hospitals, health systems and healthcare companies that promote diversity within the workforce, employee engagement and professional growth.

Pharma enthusiastic for digital medicine, but some roadblocks remain

Mobi Health News

During an afternoon roundtable session held yesterday at BIO 2018 in Boston, a panel of digital medicine and pharmaceutical representatives discussed the impact that these novel medicines has had, and could have, on drugmakers, regulators, and those prescribing the medications

Janssen funds cancer study using Vital Connect, physIQ tech

Mobi Health News

Specifically, the study — which is funded by Johnson & Johnson subsidiary Janssen Pharmaceuticals — is looking to see how the technology can detect adverse events in cancer treatment early on.

Janssen funds cancer study using VitalConnect, physIQ tech

Mobi Health News

Specifically, the study — which is funded by Johnson & Johnson subsidiary Janssen Pharmaceuticals — is looking to see how the technology can detect adverse events in cancer treatment early on.

Consumerism coming to healthcare: Opportunities and obstacles

Mobi Health News

That's true across the range of hospitals, payers and pharmaceutical companies, according to new research by branding and marketing consultancy specialist Prophet

Healthcare Roundup—First cannabis-derived drug on market; Suit claims Anthem ignored Cigna merger risks

FierceHealthIT

GW Pharmaceuticals announces doctors can begin prescribing drug derived from cannabis; Anthem faces shareholder suit and more healthcare headlines from around the web

Proteus CMO talks regulation hurdles, future plans for digital pill

Mobi Health News

It’s still the early days, but the FDA’s approval of Proteus Digital Health and Otsuka Pharmaceuticals’ Abilify MyCite has changed the discussion of digital technology in healthcare

AI Can Improve Patient Outcomes, but will Pharma Get there Quickly Enough?

Lloyd Price

Machine learning is making the drug discovery process cheaper, faster, and more optimal for all involved AI is omnipresent and it’s no shock that it’s even crept its way into the highly regulated pharmaceutical industry, one that is usually risk averse and slow to adapt new technologies.

23andMe lands $300M investment from GSK

Mobi Health News

23andMe on Wednesday announced that GlaxoSmithKline has invested $300 million to gain exclusive access to the genetic testing startup’s DNA database.

Profusa's embeddable continuous biosensor draws $45M from investors

Mobi Health News

Participants in the round included new investors VMS Investment Group, Tasly Pharmaceutical Group, and Maxim Integrated, as well as returning backers 3E Bioventures Capital and Atinum Investment. Profusa, a company that is developing connected tissue-implanted biosensors, has raised just over $45 million in Series C funding.

MedTech’s Role in Fighting the Opioid Epidemic

Duane Boise

Beginning in the 1990s, the opioid crisis was caused by a lapse in judgement by pharmaceutical companies claiming that certain painkillers did not possess addictive qualities, when in fact, they did.

Analysis shows frequent prescribers of opioids receive larger payments from pharma

FierceHealthIT

Doctors who write the most opioid prescriptions get paid the most money from the pharmaceutical companies that manufacture the drugs, an analysis by CNN and researchers at Harvard University found. Using government databases, the report found that 54% of doctors who wrote prescriptions to Medicare patients in 2014 and 2015 for opioids received a payment from pharmaceutical companies that make the drugs

In a blow to PBMs, Trump administration mulling overhaul to drug rebate safe harbor protections 

FierceHealthIT

The Trump administration is considering a proposal to overhaul safe harbor protections for pharmaceutical company rebates, a plan that could lead to a significant shift in how drug prices are determined.

Bayer-backed study looks at how patients' perceive digital products in care, clinical trials

Mobi Health News

The ongoing study is evaluating how these digital products and a Bluetooth-enabled weight scale are perceived by patients, and the feasibility of implementing such devices in future clinical trials run by the pharmaceutical company ActiGraph activity monitors and a mobile app from Clinical Ink are are at the heart of a newly announced pilot study backed by Bayer, according to a statement released today by ActiGraph.